Drug Shortage Report for HAVRIX 720 JUNIOR
Report ID | 220335 |
Drug Identification Number | 02231056 |
Brand name | HAVRIX 720 JUNIOR |
Common or Proper name | hepatitis A vaccine, inactivated |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | |
Strength(s) | 720UNIT |
Dosage form(s) | SUSPENSION |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 1's (prefilled syringe / seringue préremplie) |
ATC code | J07BC |
ATC description | VIRAL VACCINES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2024-02-21 |
Estimated end date | 2024-05-17 |
Actual end date | 2024-04-24 |
Shortage status | Resolved |
Updated date | 2024-04-25 |
Company comments | Supply available for public programs. Supply unavailable in the private market. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2024-04-25 | English | Compare |
v4 | 2024-04-24 | French | Compare |
v3 | 2024-04-24 | English | Compare |
v2 | 2024-02-23 | French | Compare |
v1 | 2024-02-23 | English | Compare |
Showing 1 to 5 of 5